Malbros Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.70 M
as on 06-07-2024
- Paid Up Capital ₹ 1.47 M
as on 06-07-2024
- Company Age 34 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -119.64%
(FY 2023)
- Ebitda -119.64%
(FY 2023)
- Net Worth -3.68%
(FY 2023)
- Total Assets -1.92%
(FY 2023)
About Malbros Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.70 M and a paid-up capital of Rs 1.47 M, as per Ministry of Corporate Affairs (MCA) records.
Vijay Katiyar, Jai Agarwal, and Ajay Jain serve as directors at the Company.
- CIN/LLPIN
U85110UP1990PTC012217
- Company No.
012217
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Aug 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Malbros Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Katiyar  | Director | 23-Jul-2004 | Current |
| Jai Agarwal | Director | 28-Mar-2005 | Current |
| Ajay Jain | Director | 31-Jan-2023 | Current |
Financial Performance of Malbros Pharmaceuticals.
Malbros Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 119.64% decrease in profit. The company's net worth dipped by a decrease of 3.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Malbros Pharmaceuticals?
In 2022, Malbros Pharmaceuticals had a promoter holding of 0.07% and a public holding of 99.93%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Raghunath Builders Private LimitedActive 30 years 3 monthsVijay Katiyar and Ajay Jain are mutual person
- Everbright Infra-Developers Private LimitedActive 19 years 27 days
Vijay Katiyar and Jai Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Malbros Pharmaceuticals?
Unlock and access historical data on people associated with Malbros Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Malbros Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Malbros Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
